Cancer stem cells in head and neck squamous cell carcinoma

Otolaryngologia Polska

Volumn 68, Issue 3, 2014, Pages 105-111

  Szafarowski, Tomasz ^a   Szczepanski, Miroslaw J ^a,b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Cancer stem cells; Head and neck squamous cell carcinoma; HNSCC; Tumor markers; Tumorigenesis

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 1A1; BETA1 INTEGRIN; CD133 ANTIGEN; CD24 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CETUXIMAB; HERMES ANTIGEN; PACLITAXEL; SARIDEGIB; UNCLASSIFIED DRUG; TUMOR MARKER;

CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STEM CELL; CARCINOGENESIS; CELL RENEWAL; DRUG RESISTANCE; DRUG TARGETING; ENZYME ACTIVITY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LARYNX CANCER; METASTASIS; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; REVIEW; SIDE POPULATION CELL; STEM CELL NICHE; TUMOR SPHEROID; TUMOR VASCULARIZATION; HEAD AND NECK TUMOR; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA;

BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASTIC STEM CELLS;

EID: 84901200585     PISSN: 00306657     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otpol.2013.10.010     Document Type: Review

References (67)

1. S. Warnakulasuriya Global epidemiology of oral and oropharyngeal cancer Oral Oncol 45 2009 309 316
2. U. Wojciechowska, J. Didkowska, W. Tarkowski, and W. Zatoński Nowotwory złośliwe w Polsce w 2003 roku 2005 Centrum Onkologii Instytut im. M. Skłodowskiej-Curie Warszawa
3. E.N. Myers Head and neck oncology - 2010, part II Otolaryngol Pol 64 2010 204 214
4. A.L. Carvalho, I.N. Nishimoto, J.A. Califano, and L.P. Kowalski Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database Int J Cancer 114 2005 806 816
5. M. Wierzbicka, E. Waśniewska, J. Jackowska, M. Leszczyńska, and W. Szyfter Routine follow-up in patients treated of head and neck cancer Otolaryngol Pol 66 2012 138 147
6. A.F. Oton-Leite, A.C. Corrêa de Castro, M.O. Morais, J.C. Pinezi, C.R. Leles, and E.F. Mendonça Effect of intraoral low-level laser therapy on quality of life of patients with head and neck cancer undergoing radiotherapy Head Neck 34 2012 398 404
7. M.E. Prince, R. Sivanandan, A. Kaczorowski, G.T. Wolf, M.J. Kaplan, and P. Dalerba et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma Proc Natl Acad Sci U S A 104 2007 973 978
8. M.S. Wicha, S. Liu, and G. Dontu Cancer stem cells: an old idea - a paradigm shift Cancer Res 66 2006 1883 1890
9. U. Günthert, M. Hofmann, W. Rudy, S. Reber, M. Zöller, and I. Haussmann et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells Cell 65 1991 13 24
10. M. Brigitte, and G. Olivier CD44s and CD44v6 expression in head and neck epithelia PLoS ONE 3 2008 10
11. P.C. Nowell The clonal evolution of tumor cell populations Science 194 1976 23 28
12. L. Ailles, and M. Prince Cancer stem cells in head and neck squamous cell carcinoma Methods Mol Biol 568 2009 175 193
13. M.E. Prince, and L.E. Ailles Cancer stem cells in head and neck squamous cell cancer J Clin Oncol 26 2008 2871 2875
14. D. Bonnet, and J.E. Dick Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cells Nat Med 3 1997 730 737
15. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci U S A 100 2003 3983 3988
16. A.V. Krivtsov, D. Twomey, Z. Feng, M.C. Stubbs, Y. Wang, and J. Faber et al. Transformation from committed progenitor to leukemia stem cell initiated by MLL-AF9 Nature 442 2006 818 822
17. M.F. Clarke, J.E. Dick, P.B. Dirks, C.J. Eaves, C.H. Jamieson, and D.L. Jones et al. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on Cancer Stem Cells Cancer Res 66 2006 9339 9344
18. J. Papailiou, K.J. Bramis, M. Gazouli, and G. Theodoropoulos Stem cells in colon cancer. A new era in cancer theory begins Int J Colorectal Dis 26 2011 1 11
19. S.J. Morrison, and A.C. Spradling Stem cells and niches: mechanisms that promote stem cell maintenance throughout life Cell 132 2008 598 611
20. G. Dontu, W.M. Abdallah, J.M. Foley, K.W. Jackson, M.F. Clarke, and M.J. Kawamura et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells Genes Dev 17 2003 1253 1270
21. S. Liu, G. Dontu, and M.S. Wicha Mammary stem cells, self renewal pathways and carcinogenesis Breast Cancer Res 7 2005 86 95
22. C.L. Olsen, P.P. Hsu, J. Glienke, G.M. Rubanyi, and A.R. Brooks Hedgehog-interacting protein is highly expressed in endothelial cells but down-regulated during angiogenesis and in several human tumors BMC Cancer 4 2004 43
23. S.I. Sayed, R. Dwivedi, R. Katna, A. Garg, K.A. Pathak, and C.M. Nutting et al. Implication of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer Oral Oncol 47 2011 237 243
24. A. Spradling, D. Drummond -Barbosa, and T. Kai Stem cells find their niche Nature 414 2001 98 104
25. C. Chen, Y. Wei, M. Hummel, T.K. Hoffmann, M. Gross, and A.M. Kaufmann et al. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma PLoS ONE 6 2011 e16466
26. I.K. Park, S.J. Morrison, and M.F. Clarke Bmi1, stem cells, and senescence regulation J Clin Invest 113 2004 175 179
27. S. Liu, G. Dontu, I.D. Mantle, S. Patel, N.S. Ahn, and K.W. Jackson et al. Hedgehog signaling and BMI-1 regulate self-renewal of normal and malignant human mammary stem cells Cancer Res 66 2006 6063 6071
28. L.B. Song, J. Li, W.T. Liao, Y. Feng, C.P. Yu, and L.J. Hu et al. The polycomb group protein Bmi-1 repressed the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells J Clin Invest 119 2009 3626 3636
29. E. Allegra, and S. Trapasso Cancer stem cells in head and neck cancer Onco Targets Ther 5 2012 375 383
30. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 1971 1182 1186
31. K.G. Neiva, Z. Zhang, M. Miyazawa, K.A. Warner, E. Karl, and J.E. Nör Crosstalk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT/Akt/ERK signaling Neoplasia 11 2009 583 593
32. Z. Zhang, K.G. Neiva, M.W. Lingen, L.M. Ellis, and J.E. Nör VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2 Cell Death Differ 17 2010 499 512
33. I. Fidlel, and L. Ellis Neoplastic angiogenesis- not all blood vessels are created equal N Eng J Med 351 2004 215 216
34. A. Giatromanolaki, E. Sivridis, and M. Koukourakis Tumor angiogenesis: vascular growth and survival APMIS 112 2004 431 440
35. S. Krishnamurthy, Z. Dong, D. Vodopyanov, A. Imai, J.I. Helman, and M.E. Prince et al. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells Cancer Res 70 2010 9969 9978
36. Z. Zhang, M.S. Filho, and J. Nor The biology of head and neck cancer stem cells Oral Oncol 48 2012 1 9
37. K. Shakib, A. Schrattenholz, and V. Soskic Stem cells in head and neck squamous cell carcinoma Br J Oral Maxillofac Surg 49 2011 503 506
38. P.J. Barth, S. Schweinsberg, and A. Ramaswamy CD 34 B fibrocytes, alpha-amooth muscle antigen-positive yo fibroblasts, and CD117 expression in the stroma of invasive squamosus cell carcinomas of the oral cavity, pharynx, and larynx Virchows Arch 444 2004 231 234
39. S. Staibano, F. Merolla, D. Testa, R. Iovine, M. Mascolo, and V. Guarino et al. OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome Br J Cancer 97 2007 1545 1551
40. C.M. Isacke, and H. Yarwood The hyaluronan receptor, CD44 Int J Biochem Cell Biol 34 2002 718 721
41. N. Bauer, A.V. Fonseca, M. Florek, D. Freund, J. Jászai, and M. Bornhäuser et al. New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133) Cells Tissues Organs 188 2008 127 138
42. G. Kristiansen, C. Denkert, K. Schlüns, E. Dahl, C. Pilarsky, and S. Hauptmann CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patients survival Am J Pathol 161 2002 1215 1221
43. J. Pruszak, W. Ludwig, A. Blak, K. Alavian, and O. Isacson CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells Stem Cells 27 2009 2928 2940
44. H. Stockinger, S.J. Gadd, R. Eher, O. Majdic, W. Schreiber, and W. Kasinrerk et al. Molecular characterization and functional analysis of the leukocyte surface protein CD31 J. Immunol 145 1991 3889 3897
45. M.R. Clay, M. Tabor, J.H. Owen, T.E. Carey, C.R. Bradford, and G.T. Wolf et al. Singlemarker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase Head Neck 32 2010 1195 1201
46. G. Duester Families of retinoid dehydrogenases regulating vitamin A function Eur J Biochem 267 2000 4315 4324
47. F. Giannini, R. Maestro, T. Vukosavljevic, F. Pomponi, and M. Boiocchi All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use Int J Cancer 70 1997 194 200
48. A.M. Simeone, and A.M. Tari How retinoids regulate breast cancer cell proliferation and apoptosis Cell Mol Life Sci 61 2004 1475 1484
49. M.J. Szczepański, and T.L. Whiteside Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma? Biomark Med 7 2013 575 578
50. S.K. Singh, C. Hawkins, I.D. Clarke, J.A. Squire, J. Bayani, and T. Hide et al. Identification of human brain tumour initiating cells Nature 432 2004 396 401
51. D. Ponti, A. Costa, N. Zaffaroni, G. Pratesi, G. Petrangolini, and D. Coradini et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties Cancer Res 65 2005 5506 5511
52. A. Okamoto, K. Chikamatsu, K. Sakakura, K. Hatsushika, G. Takahashi, and K. Masuyama Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck Oral Oncol 45 2009 633 639
53. P. Zhang, Y. Zhang, L. Mao, Z. Zhang, and W. Chen Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes Cancer Lett 277 2009 227 234
54. M.M. Ho, A.V. Ng, S. Lam, and J.Y. Hung Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells Cancer Res. 67 2007 4827 4833
55. M.R. Loebinger, A. Giangreco, K.R. Groot, L. Prichard, K. Allen, and C. Simpson et al. Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade Br J Cancer 98 2008 380 387
56. M.H. Tabor, M.R. Clay, J.H. Owen, C.R. Bradford, T.E. Carey, and G.T. Wolf et al. Head and neck cancer stem cells: the side population Laryngoscope 121 2011 527 533
57. M.C. de Jong, J. Pramana, J.E. van der Wal, M. Lacko, C.J. Peutz-Kootstra, and J.M. de Jong et al. CD44 expression predicts local recurrence after radiotherapy in larynx cancer Clin Cancer Res 16 2010 5329 5338
58. Y.W. Chen, K.H. Chen, P.I. Huang, Y.C. Chen, G.Y. Chiou, and W.L. Lo et al. Cucurbitacin I Suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma-derived CD44+ALDH+ cells Mol Cancer Ther 9 2010 2879 2892
59. Q. Zhang, S. Shi, Y. Yen, J. Brown, J.Q. Ta, and A.D. Le A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy Cancer Lett 289 2010 151 160
60. A. Okamoto, K. Chikamatsu, K. Sakakura, K. Hatsushika, G. Takahashi, and K. Masuyama Expansion and characterization of cancer stem-like cells in squamous cells carcinoma of the head and neck Oral Oncol 45 2009 633 639
61. C. Ginestier, M.H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, and M. Brown et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 2007 555 567
62. E. Charafe-Jauffret, C. Ginestier, F. Lovino, C. Tarpin, M. Diebel, and B. Esterni et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer Clin Cancer Res 16 2010 45 55
63. Y.C. Chen, Y.W. Chen, H.S. Hsu, L.M. Tseng, P.I. Huang, and K.H. Lu et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer Biochem Biophys Res Commun 385 2009 307 313
64. A. Forastiere, W. Koch, A. Trotti, and D. Sidransky Head and neck cancer N Engl J Med. 345 2001 1890 1900
65. T. Klonisch, E. Wiechec, S. Hombach-Klonisch, S.R. Ande, S. Wesselborg, and K. Schulze-Osthoff et al. Cancer stem cell markers in common cancers - therapeutic implications Trends Mol Med 14 2008 450 460
66. C. Folkins, S. Man, P. Xu, Y. Shaked, D.J. Hicklin, and R.S. Kerbel Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors Cancer Res 67 2007 3560 3564
67. Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck Cancer: In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medecine (US). 2000, http://clinicaltrial.gov/ct2/show/NCT01255800 (cited 03.30.12).